Previous reports have implicated the role of BCL9 in tumor development [31, 32] and our study further disclosed the pro-tumor effects of BCL9 paralog BCL9L, which could promote the β-catenin signals activation in gastric cancer. The gene discussed is BCL9; the disease is neoplasm.